← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2011Last known activity
Jan 1, 2017
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 2 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Indications
Recent trials (3)
- NCT02812355Reponsible party - principal investigatorPhase 4Jan 1, 2017
- NCT02812355Lead sponsorPhase 4Jan 1, 2017
- NCT01432496CollaboratorPhase 3Sep 1, 2011
Details
- Last known activity
- Jan 1, 2017